Tag: #immunotherapy

Durvalumab Plus FLOT Boosts Survival in Resectable Gastric and GEJ Cancer, MATTERHORN Shows

Phase 3 MATTERHORN shows AstraZeneca’s durvalumab added to perioperative FLOT improves overall and event‑free survival in resectable gastric/GEJ cancer.

$AZN, #oncology, #immunotherapy, #durvalumab, #gastric-cancer, #astrazeneca

NHS England rolls out 60-second pembrolizumab injection to cut treatment chair time

NHS England is introducing a subcutaneous form of pembrolizumab (Keytruda) that can be given in about a minute, reducing clinic time for roughly 14,000 patients.

#nhs, #pembrolizumab, #cancer, #immunotherapy

Study: dual‑target off‑the‑shelf CAR‑T cells resist rejection, curb tumor escape in mice

Nature Communications study finds donor 'off‑the‑shelf' CAR‑T cells targeting CD19 and CD70 persist longer and better control tumors in preclinical models.

$ALLO, #car-t, #immunotherapy, #allogeneic, #cd70